Flucelvax® Quadrivalent (influenza vaccine) – Expanded indication
October 14, 2021 - The FDA approved Seqirus’ Flucelvax Quadrivalent (influenza vaccine), for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and types B contained in the vaccine. Flucelvax Quadrivalent is approved for use in persons 6 months of age and older.
Top